NASDAQ:PHIO | Free Cash Flow | Phio Pharmaceuticals Corp.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4M$0.00-$4M
2025-12-31-$2.08M$0.00-$2.08M
2025-03-31-$1.28M$2,000.00-$1.28M
2024-12-31-$1.37M$1,000.00-$1.37M
2024-03-31-$2.01M$0.00-$2.01M
2023-12-31-$2.37M$0.00-$2.37M
2023-03-31-$2.71M$0.00-$2.71M
2022-12-31-$2.71M$0.00-$2.71M
2022-03-31-$3.47M$104,000.00-$3.57M
2021-12-31-$2.47M$0.00-$2.47M
2021-03-31-$3.27M$6,000.00-$3.27M
2020-12-31-$2.62M$1,000.00-$2.62M
2020-03-31-$2.18M$10,000.00-$2.19M
2019-12-31-$2.55M-$5,000.00-$2.55M
2019-03-31-$2.18M$1,000.00-$2.18M
2018-12-31-$1.75M$5,000.00-$1.75M
2018-03-31-$1.91M$0.00-$1.91M
2017-12-31-$2.2M$0.00-$2.2M
2017-03-31-$2.8M$2,000.00-$2.8M
2016-12-31-$1.37M$2,000.00-$1.37M
2016-03-31-$2.93M
2015-12-31-$1.58M$18,000.00-$1.6M
2015-03-31-$1.97M$8,000.00-$1.98M
2014-12-31-$1.6M$9,000.00-$1.6M
2014-03-31-$2.38M
2013-12-31-$1.4M$68,000.00-$1.47M
2013-03-31-$1.13M
2012-12-31-$1.15M$6,000.00-$1.16M
2012-03-31-$1.21M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$7.98M$12,000.00-$7.99M
2024-12-31-$7.11M$1,000.00-$7.11M
2023-12-31-$10.75M$5,000.00-$10.75M
2022-12-31-$12.13M$121,000.00-$12.25M
2021-12-31-$11.86M$51,000.00-$11.91M
2020-12-31-$8.8M$19,000.00-$8.82M
2019-12-31-$8.65M$72,000.00-$8.72M
2018-12-31-$7.52M$5,000.00-$7.53M
2017-12-31-$9.51M$203,000.00-$9.72M
2016-12-31-$7.76M$4,000.00-$7.76M
2015-12-31-$7.32M$57,000.00-$7.37M
2014-12-31-$7.76M$95,000.00-$7.85M
2013-12-31-$6.31M$78,000.00-$6.39M
2012-12-31-$5.06M$15,000.00-$5.08M